Arkolith/Insider Trading/SRRA/Form 4

Norrett Kevin

Chief Business OfficerSierra Oncology, Inc. (SRRA) · full profile →Form 4 · filed Jul 1, 2022
No Open-Market Flow
Open-Market Buys
$0
Open-Market Sells
$0
Net Open-Market Flow
$0
Transactions
4
0 non-derivative · 4 derivative

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Jul 1, 2022Disposed to issuer(D)100K—$00
Jul 1, 2022Disposed to issuer(D)49K—$00
Jul 1, 2022Disposed to issuer(D)12K—$00
Jul 1, 2022Disposed to issuer(D)35K—$00

Transaction Codes

D
Disposition to the issuer

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001209191-22-040236) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML